Jay Luther

3.0k total citations
66 papers, 2.2k citations indexed

About

Jay Luther is a scholar working on Epidemiology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Jay Luther has authored 66 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 17 papers in Pathology and Forensic Medicine and 14 papers in Surgery. Recurrent topics in Jay Luther's work include Liver Disease Diagnosis and Treatment (18 papers), Alcohol Consumption and Health Effects (14 papers) and Microscopic Colitis (12 papers). Jay Luther is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Alcohol Consumption and Health Effects (14 papers) and Microscopic Colitis (12 papers). Jay Luther collaborates with scholars based in United States, Taiwan and United Kingdom. Jay Luther's co-authors include John Y. Kao, Peter Higgins, Maneesh Dave, Chun-Chia Chen, Stephanie Y. Owyang, Suraj J. Patel, Tyler S. Cole, John J. Garber, William D. Chey and Raymond T. Chung and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Jay Luther

62 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay Luther United States 24 868 708 600 469 346 66 2.2k
Kristen O. Arseneau United States 26 545 0.6× 556 0.8× 589 1.0× 723 1.5× 789 2.3× 36 2.3k
Hongjie Zhang China 27 565 0.7× 402 0.6× 430 0.7× 905 1.9× 597 1.7× 87 2.2k
Rasmus Goll Norway 30 547 0.6× 607 0.9× 756 1.3× 666 1.4× 722 2.1× 89 2.4k
Lisa S. Poritz United States 26 899 1.0× 506 0.7× 302 0.5× 549 1.2× 706 2.0× 68 2.2k
Luca Pastorelli Italy 24 840 1.0× 383 0.5× 935 1.6× 501 1.1× 697 2.0× 77 2.3k
Ulrike Strauch Germany 28 589 0.7× 526 0.7× 1.2k 2.1× 593 1.3× 866 2.5× 48 2.9k
Jesús K. Yamamoto‐Furusho Mexico 29 604 0.7× 864 1.2× 1.1k 1.8× 738 1.6× 1.3k 3.9× 176 3.1k
Neil Shah United Kingdom 36 1.4k 1.6× 500 0.7× 980 1.6× 425 0.9× 1.0k 3.0× 116 3.7k
Kouhei Fukushima Japan 25 689 0.8× 466 0.7× 435 0.7× 508 1.1× 756 2.2× 111 2.3k
Deanna D. Nguyen United States 27 616 0.7× 765 1.1× 621 1.0× 474 1.0× 1.2k 3.4× 72 2.5k

Countries citing papers authored by Jay Luther

Since Specialization
Citations

This map shows the geographic impact of Jay Luther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Luther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Luther more than expected).

Fields of papers citing papers by Jay Luther

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Luther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Luther. The network helps show where Jay Luther may publish in the future.

Co-authorship network of co-authors of Jay Luther

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Luther. A scholar is included among the top collaborators of Jay Luther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Luther. Jay Luther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, Richard, Guruprasad P. Aithal, Michael Allison, et al.. (2025). Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease. The American Journal of Gastroenterology.
2.
Corey, Kathleen E., et al.. (2024). Prevalence and Clinical Correlation of Cardiometabolic Risk Factors in Alcohol-Related Liver Disease and Metabolic Dysfunction and Alcohol Associated Liver Disease (MetALD). Journal of Clinical and Experimental Hepatology. 15(3). 102492–102492. 3 indexed citations
3.
Shay, Jessica E.S., Augustin Vannier, Stephanie Tsai, et al.. (2023). Moderate-high intensity exercise associates with reduced incident alcohol-associated liver disease in high-risk patients. Alcohol and Alcoholism. 58(5). 472–477. 3 indexed citations
4.
Tsai, Stephanie, et al.. (2022). Creation of an Inpatient Alcohol Liver Service Improves Early Liver Disease Detection in Patients With Alcohol Use Disorder. Clinical Gastroenterology and Hepatology. 21(6). 1646–1648. 13 indexed citations
5.
Luther, Jay & Lawrence S. Friedman. (2021). Management of Thrombocytopenia and Coagulopathy in Patients with Chronic Liver Disease Undergoing Therapeutic Endoscopic Interventions. Clinics in Liver Disease. 26(1). 1–12. 1 indexed citations
6.
Luther, Jay, Sanjoy K. Khan, Manish Gala, et al.. (2020). Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation. Proceedings of the National Academy of Sciences. 117(21). 11667–11673. 69 indexed citations
7.
Tran, Gloria, Nienke Z. Borren, Danny J. Avalos, et al.. (2018). Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis. Clinical Gastroenterology and Hepatology. 17(3). 502–509.e1. 64 indexed citations
8.
Luther, Jay, Manish Gala, Suraj J. Patel, et al.. (2018). Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn’s Disease Is Not Associated with Emergence of Novel Inflammatory Pathways. Digestive Diseases and Sciences. 63(3). 738–745. 19 indexed citations
9.
Dave, Maneesh, et al.. (2015). Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 21(11). 2696–2707. 74 indexed citations
10.
Luther, Jay, John J. Garber, Maneesh Dave, et al.. (2015). Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability. Cellular and Molecular Gastroenterology and Hepatology. 1(2). 222–232.e2. 224 indexed citations
11.
Jilg, Nikolaus, Wenyu Lin, Jian Hong, et al.. (2013). Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus. Hepatology. 59(4). 1250–1261. 89 indexed citations
12.
Cole, Tyler S., Theodore J. Standiford, Michael W. Newstead, et al.. (2012). IRAK-M modulates expression of IL-10 and cell surface markers CD80 and MHC II after bacterial re-stimulation of tolerized dendritic cells. Immunology Letters. 144(1-2). 49–59. 19 indexed citations
13.
Luther, Jay, et al.. (2011). Anaplastic Lymphoma Masquerading as Sclerosing Mesenteritis: A Case Report. Journal of Gastrointestinal Cancer. 43(2). 364–366. 4 indexed citations
14.
Higgins, Peter, Laura A. Johnson, Jay Luther, et al.. (2010). Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis. Inflammatory Bowel Diseases. 17(6). 1398–1408. 64 indexed citations
15.
Luther, Jay, Maneesh Dave, Peter Higgins, & John Y. Kao. (2009). Association between Helicobacter pylori infection and inflammatory bowel disease. Inflammatory Bowel Diseases. 16(6). 1077–1084. 173 indexed citations
16.
Kao, John Y., Min Zhang, Mark J. Miller, et al.. (2009). Helicobacter pylori Immune Escape Is Mediated by Dendritic Cell–Induced Treg Skewing and Th17 Suppression in Mice. Gastroenterology. 138(3). 1046–1054. 246 indexed citations
17.
Luther, Jay & Marshall J. Glesby. (2007). Dermatologic Adverse Effects of Antiretroviral Therapy. American Journal of Clinical Dermatology. 8(4). 221–233. 34 indexed citations
18.
Havlin, Kathleen A., John G. Kuhn, John B. Craig, et al.. (1991). Phase I evaluation of 773U82 HCI, a member of a new class of DNA intercalators. Anti-Cancer Drugs. 2(4). 357–364.
19.
Cobb, Patrick, Kathleen A. Havlin, John G. Kuhn, et al.. (1991). Phase I Evaluation of Crisnatol (BWA770U Mesylate) on a Monthly Extended Infusion Schedule. PubMed. 7(2). 85–91. 2 indexed citations
20.
Craig, John B., John G. Kuhn, Jay Luther, et al.. (1988). Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule.. PubMed. 48(16). 4706–10. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristen O. Arseneau Breakdown of academic impact, for papers by Hongjie Zhang Breakdown of academic impact, for papers by Rasmus Goll Breakdown of academic impact, for papers by Lisa S. Poritz Breakdown of academic impact, for papers by Luca Pastorelli Breakdown of academic impact, for papers by Ulrike Strauch Breakdown of academic impact, for papers by Jesús K. Yamamoto‐Furusho Breakdown of academic impact, for papers by Neil Shah Breakdown of academic impact, for papers by Kouhei Fukushima Breakdown of academic impact, for papers by Deanna D. Nguyen
Rankless by CCL
2026